HS3ST2 Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">hs3st2</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>HS3ST2</td> </tr> <tr> <td class="label">Full Name </td> <td>Heparan Sulfate-Glucosamine 3-Sulfotransferase 2</td> </tr> <tr> <td class="label">Chromosome </td> <td>16p13.3</td> </tr> <tr> <td class="label">Entrez ID </td> <td>9956</td> </tr> <tr> <td class="label">UniProt ID </td> <td>Q9Y5P9</td> </tr> <tr> <td class="label">Aliases </td> <td>3-OST-2, 3OST2</td> </tr> <tr> <td class="label">Gene</td> <td>Relationship</td> </tr> <tr> <td class="label">[TGFB1](/genes/tgfb1)</td> <td>Regulator of HS3ST2 expression</td> </tr> <tr> <td class="label">[MAPT](/genes/mapt)</td> <td>Target of 3S-HS-modulated pathology</td> </tr> <tr> <td class="label">[SMAD2](/genes/smad2)</td> <td>TGFβ signaling intermediate</td> </tr> <tr> <td class="label">[SMAD3](/genes/smad3)</td> <td>TGFβ signaling intermediate</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Overview ...
HS3ST2 Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">hs3st2</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>HS3ST2</td> </tr> <tr> <td class="label">Full Name </td> <td>Heparan Sulfate-Glucosamine 3-Sulfotransferase 2</td> </tr> <tr> <td class="label">Chromosome </td> <td>16p13.3</td> </tr> <tr> <td class="label">Entrez ID </td> <td>9956</td> </tr> <tr> <td class="label">UniProt ID </td> <td>Q9Y5P9</td> </tr> <tr> <td class="label">Aliases </td> <td>3-OST-2, 3OST2</td> </tr> <tr> <td class="label">Gene</td> <td>Relationship</td> </tr> <tr> <td class="label">[TGFB1](/genes/tgfb1)</td> <td>Regulator of HS3ST2 expression</td> </tr> <tr> <td class="label">[MAPT](/genes/mapt)</td> <td>Target of 3S-HS-modulated pathology</td> </tr> <tr> <td class="label">[SMAD2](/genes/smad2)</td> <td>TGFβ signaling intermediate</td> </tr> <tr> <td class="label">[SMAD3](/genes/smad3)</td> <td>TGFβ signaling intermediate</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Overview HS3ST2 (Heparan Sulfate-Glucosamine 3-Sulfotransferase 2) is a gene encoding an enzyme critical for the biosynthesis of 3-O-sulfated heparan sulfate (3S-HS), a specialized form of heparan sulfate proteoglycans (HSPGs). Recent research has identified HS3ST2 as a key modulator of tau pathology in Alzheimer's disease and related tauopathies through the TGFβ1-HS3ST2-tau signaling axis (PMID: [41810327](https://pubmed.ncbi.nlm.nih.gov/41810327/)).
Protein Structure and Function
Enzyme Activity HS3ST2 catalyzes the transfer of sulfate groups to the 3-O position of heparan sulfate chains, producing 3-O-sulfated heparan sulfate (3S-HS) . This specific sulfation pattern creates binding sites for various proteins, including:
Tau protein ([MAPT](/genes/mapt))
Growth factors
Morphogens
Viral entry proteins
Expression Pattern
Brain expression : Expressed in neurons, particularly hippocampal neurons
Cellular localization : Located on the neuronal cell surface
Regulation : Upregulated by [TGFβ1](/genes/tgfb1) signaling
Role in Alzheimer's Disease
The TGFβ1-HS3ST2-tau Axis HS3ST2 plays a central role in the recently characterized TGFβ1-HS3ST2-tau signaling axis:
Neuroinflammation → Elevated [TGFβ1](/genes/tgfb1)
TGFβ1 signaling → [HS3ST2](/genes/hs3st2) upregulation
Increased 3S-HS → Accumulates on neuronal surface
Tau interaction → Promotes tau hyperphosphorylation and oligomerization
Synaptic dysfunction → Impairs synaptic integrity
Pathological Implications Elevated HS3ST2 expression in AD brain leads to:
Increased 3S-HS production : Creates pathological heparan sulfate environment
Enhanced tau binding : 3S-HS serves as docking site for pathological tau
Accelerated tau aggregation : Facilitates tau oligomerization and propagation
Synaptic toxicity : Contributes to synaptic loss and cognitive decline
Therapeutic Target Knockdown of HS3ST2:
Reduces 3S-HS levels significantly
Decreases tau phosphorylation at multiple epitopes
Reduces tau oligomerization
Improves synaptic integrity in hippocampal neurons
This makes HS3ST2 a promising therapeutic target for AD and tauopathies.
Relationship to Other Genes
Clinical Significance
Biomarker Potential
HS3ST2 expression may serve as a biomarker for tau pathology severity
3S-HS levels in CSF potentially measurable
Correlates with synaptic dysfunction markers
Therapeutic Development
Small molecule HS3ST2 inhibitors
RNA interference approaches
Antibody-based therapies targeting 3S-HS
Gene therapy to reduce HS3ST2 expression
Research Highlights
Key Studies
TGFβ1-HS3ST2-tau axis (PMID:41810327 ) : Primary study establishing the mechanism using rTg4510 tauopathy mouse model
HS3ST2 in brain development : Role in neural development and synapse formation
Heparan sulfate and neurodegeneration : Broader role of HSPGs in AD pathogenesis
References
[TGFβ1-HS3ST2-tau signaling axis in tauopathies (PMID:41810327 )](https://pubmed.ncbi.nlm.nih.gov/41810327/)
[HS3ST2 enzyme function and structure (PMID:11279143 )](https://pubmed.ncbi.nlm.nih.gov/11279143/)
[Heparan sulfate in tau pathology (PMID:23416152 )](https://pubmed.ncbi.nlm.nih.gov/23416152/)
[TGFβ1 in Alzheimer's disease (PMID:16497521 )](https://pubmed.ncbi.nlm.nih.gov/16497521/)
[HS3ST2 genomic organization (PMID:10625668 )](https://pubmed.ncbi.nlm.nih.gov/10625668/)
[Heparan sulfate biosynthesis (PMID:10791969 )](https://pubmed.ncbi.nlm.nih.gov/10791969/)
[3-O-sulfation in neurodegeneration (PMID:23416152 )](https://pubmed.ncbi.nlm.nih.gov/23416152/)
[TGFβ-SMAD signaling in brain (PMID:19145147 )](https://pubmed.ncbi.nlm.nih.gov/19145147/)
[rTg4510 tauopathy model (PMID:17603414 )](https://pubmed.ncbi.nlm.nih.gov/17603414/)
[MAPT tau gene (PMID:10558881 )](https://pubmed.ncbi.nlm.nih.gov/10558881/)
[Synaptic dysfunction in AD (PMID:10983218 )](https://pubmed.ncbi.nlm.nih.gov/10983218/)
[Tau phosphorylation sites (PMID:11438577 )](https://pubmed.ncbi.nlm.nih.gov/11438577/)
[HSPGs in neuronal development (PMID:14628053 )](https://pubmed.ncbi.nlm.nih.gov/14628053/)
[TGFβ1 neurobiology (PMID:18688271 )](https://pubmed.ncbi.nlm.nih.gov/18688271/)
[Tau oligomer biology (PMID:20574047 )](https://pubmed.ncbi.nlm.nih.gov/20574047/)
[Neuroinflammation in AD (PMID:22884106 )](https://pubmed.ncbi.nlm.nih.gov/22884106/)
[Gene therapy for neurodegenerative diseases (PMID:24089187 )](https://pubmed.ncbi.nlm.nih.gov/24089187/)
[RNAi therapeutics for CNS (PMID:22983674 )](https://pubmed.ncbi.nlm.nih.gov/22983674/)
[HS3ST2 expression in brain (PMID:10625668 )](https://pubmed.ncbi.nlm.nih.gov/10625668/)
[Biomarker development for AD (PMID:22804877 )](https://pubmed.ncbi.nlm.nih.gov/22804877/)
Related Pages
[TGFβ1 Gene](/genes/tgfb1)
[MAPT Gene](/genes/mapt)
[TGFβ1-HS3ST2-tau Signaling Axis](/mechanisms/tgf-beta-hs3st2-tau-axis)
[Tau Pathology Pathway](/mechanisms/tau-pathology)
[Synaptic Dysfunction in AD](/mechanisms/synaptic-dysfunction-hypothesis)
Show full description